Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;17(1):e2100137.
doi: 10.1002/biot.202100137. Epub 2021 Oct 8.

Intravenous injection of mesenchymal stem cell spheroids improves the pulmonary delivery and prolongs in vivo survival

Yoshihiko Shimazawa  1 , Kosuke Kusamori  1 , Mari Tsujimura  1 , Asuka Shimomura  1 , Ryo Takasaki  1 , Yukiya Takayama  1 , Kazunori Shimizu  2 , Satoshi Konishi  3 , Makiya Nishikawa  1
Affiliations

Intravenous injection of mesenchymal stem cell spheroids improves the pulmonary delivery and prolongs in vivo survival

Yoshihiko Shimazawa et al. Biotechnol J. 2022 Jan.

Abstract

Background: Because of the excellent therapeutic potential, mesenchymal stem cells (MSCs) have been used as cell therapeutics for various diseases. However, the survival rate and duration of MSCs after transplantation are extremely low and short, respectively. To solve these problems, in this study, we prepared multicellular spheroids of MSCs and investigated their survival and function after intravenous injection in mice.

Methods and results: The murine adipose-derived MSC line m17.ASC was cultured in agarose-based microwell plates to obtain size-controlled m17.ASC spheroids of an average diameter and cell number of approximately 170 μm and 1100 cells/spheroid, respectively. The intravenously injected m17.ASC spheroids mainly accumulated in the lung and showed a higher survival rate than suspended m17.ASC cells during the experimental period of 7 days. m17.ASC spheroids efficiently reduced the lipopolysaccharide-induced increase in plasma concentrations of interleukin-6 and tumor necrosis factor-α.

Conclusions: These results indicate that spheroid formation improved the pulmonary delivery and survival of MSCs, as well as their therapeutic potential against inflammatory pulmonary diseases.

Keywords: biodistribution; cell transplantation; mesenchymal stem cells; micromolding technique; multicellular spheroids.

PubMed Disclaimer

References

REFERENCES

    1. Voswinkel, J., Francois, S., Simon, J. M., Benderitter, M., Gorin, N. C., Mohty, M., Fouillard, L., & Chapel, A. (2013). Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: A comprehensive review. Clinical Reviews in Allergy and Immunology 45, 180-192.
    1. Fekete, N., Rojewski, M. T., Fürst, D., Kreja, L., Ignatius, A., Dausend, J., & Schrezenmeier, H. (2012). GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. Plos One 7, e43255.
    1. Hass, R., Kasper, C., Bohm, S., & Jacobs, R. (2011). Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. The Journal of Cell Communication and Signaling 9(12), 1-14.
    1. Muroi, K., Miyamura, K., Okada, M., Yamashita, T., Murata, M., Ishikawa, T., Uike, N., Hidaka, M., Kobayashi, R., Imamura, M., Tanaka, J., Ohashi, K., Taniguchi, S., Ikeda, T., Eto, T., Mori, M., Yamaoka, M., & Ozawa, K. (2016). Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: A phase II/III study. International Journal of Hematology 103, 243-250.
    1. Tyndall, A., & Houssiau, A. (2010). Mesenchymal stem cells in the treatment of autoimmune diseases. Annals of the Rheumatic Diseases 69, 1413-1414.

Grants and funding

LinkOut - more resources